CC The Chemours Company
CC The Chemours Company
Basic Materials · Specialty Chemicals
Market read
POC $15.28 · VWAP $17.18 · -8.5% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
CC Price Structure
Loading timeframes…
Peers
Every watchlist CC belongs to, members best 30-day change first — CC highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-03-31: revenue $1.38B, diluted EPS $-0.19, net income $-29M (SEC filing). Across the print the stock moved -13.0% (close before → first close after).
full note →Against street estimates
How CC's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about CC from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 42 days ago · Jul 7
- The Chemours Company (CC) Stock Price & Overview
- The Chemours Company (CC) Earnings Dates & Report | Seeking Alpha
- Chemours (CC) Earnings Date and Reports 2026 - MarketBeat
- Chemours (CC) Earnings Report: Key Numbers & Transcript Summary
- CC Stock Earnings: Chemours Beats EPS, Meets Revenue for Q1 2024 | Markets Insider
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CC research tape
6 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.